Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2003 1
2004 4
2005 3
2006 2
2007 2
2008 2
2010 3
2011 4
2012 10
2013 10
2014 8
2015 12
2016 20
2017 24
2018 18
2019 14
2020 16
2021 19
2022 10
2023 17
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
D'Angelica MI, Ellis RJ, Liu JB, Brajcich BC, Gönen M, Thompson VM, Cohen ME, Seo SK, Zabor EC, Babicky ML, Bentrem DJ, Behrman SW, Bertens KA, Celinski SA, Chan CHF, Dillhoff M, Dixon MEB, Fernandez-Del Castillo C, Gholami S, House MG, Karanicolas PJ, Lavu H, Maithel SK, McAuliffe JC, Ott MJ, Reames BN, Sanford DE, Sarpel U, Scaife CL, Serrano PE, Smith T, Snyder RA, Talamonti MS, Weber SM, Yopp AC, Pitt HA, Ko CY. D'Angelica MI, et al. Among authors: yopp ac. JAMA. 2023 May 9;329(18):1579-1588. doi: 10.1001/jama.2023.5728. JAMA. 2023. PMID: 37078771 Free PMC article.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Among authors: yopp ac. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
Hepatocellular Carcinoma.
Yopp AC, Majella Doyle MB. Yopp AC, et al. Surg Oncol Clin N Am. 2024 Jan;33(1):xv-xvi. doi: 10.1016/j.soc.2023.07.002. Epub 2023 Aug 12. Surg Oncol Clin N Am. 2024. PMID: 37945150 No abstract available.
Reply.
Atiq O, Tiro J, Yopp AC, Muffler A, Marrero JA, Parikh ND, Murphy C, McCallister K, Singal AG. Atiq O, et al. Among authors: yopp ac. Hepatology. 2017 Sep;66(3):1002-1003. doi: 10.1002/hep.29286. Epub 2017 Jul 31. Hepatology. 2017. PMID: 28543272 Free article. No abstract available.
Presente y futuro de la vigilancia del carcinoma hepatocelular.
Rahimi RS, Yopp AC, Singal AG. Rahimi RS, et al. Among authors: yopp ac. Clin Liver Dis (Hoboken). 2014 Jan 13;2(Suppl 5):87-90. doi: 10.1002/cld.281. eCollection 2013 Nov. Clin Liver Dis (Hoboken). 2014. PMID: 31333832 Free PMC article. Review. Spanish. No abstract available.
Surgical Therapies in Hepatocellular Carcinoma.
Hester CA, Yopp AC. Hester CA, et al. Among authors: yopp ac. 2019 Aug 6. In: Hoshida Y, editor. Hepatocellular Carcinoma: Translational Precision Medicine Approaches [Internet]. Cham (CH): Humana Press; 2019. Chapter 8. 2019 Aug 6. In: Hoshida Y, editor. Hepatocellular Carcinoma: Translational Precision Medicine Approaches [Internet]. Cham (CH): Humana Press; 2019. Chapter 8. PMID: 32078277 Free Books & Documents. Review.
Medical Management of Hepatocellular Carcinoma.
Rich NE, Yopp AC, Singal AG. Rich NE, et al. Among authors: yopp ac. J Oncol Pract. 2017 Jun;13(6):356-364. doi: 10.1200/JOP.2017.022996. J Oncol Pract. 2017. PMID: 28605614 Review.
Management of hepatocellular in the United States.
Mokdad AA, Hester CA, Singal AG, Yopp AC. Mokdad AA, et al. Among authors: yopp ac. Chin Clin Oncol. 2017 Apr;6(2):21. doi: 10.21037/cco.2017.04.04. Chin Clin Oncol. 2017. PMID: 28482674 Free article. Review.
A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis.
Fujiwara N, Kobayashi M, Fobar AJ, Hoshida A, Marquez CA, Koneru B, Panda G, Taguri M, Qian T, Raman I, Li QZ, Hoshida H, Sezaki H, Kumada H, Tateishi R, Yokoo T, Yopp AC, Chung RT, Fuchs BC, Baumert TF, Marrero JA, Parikh ND, Zhu S, Singal AG, Hoshida Y. Fujiwara N, et al. Among authors: yopp ac. Med. 2021 Jul 9;2(7):836-850.e10. doi: 10.1016/j.medj.2021.03.017. Epub 2021 Apr 21. Med. 2021. PMID: 34318286 Free PMC article.
163 results